Clinical trial
The Effect of Fluid Resuscitation with 20% Albumin Versus Crystalloid on the Microcirculation of Patients with Sepsis
NCT05357339 is registered in ClinicalTrials.gov with Rachael Cusack as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Fluid Resuscitation with 20% Albumin Versus Crystalloid on the Microcirculation of Patients with Sepsis
- Lead sponsor
- Rachael Cusack
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 1, 2021
- Completion date
- December 1, 2023
- Enrollment
- 100 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
sepsis, sepsis, severe, septic shock